Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies

Ning Yin, Yi Liu, Nicole R. Murray, Alan P. Fields

Research output: Contribution to journalArticle

1 Scopus citations


Protein Kinase Cι (PKCι) is a major oncogene involved in the initiation, maintenance and progression of numerous forms of human cancer. In the lung, PKCι is necessary for the maintenance of the transformed phenotype of the two major forms of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC). In addition, PKCι is necessary for both LADC and LSCC tumorigenesis by establishing and maintaining a highly aggressive stem-like, tumor-initiating cell phenotype. Interestingly however, while PKCι signaling in these two major lung cancer subtypes shares some common elements, it also drives distinct, sub-type specific pathways. Furthermore, recent analysis has revealed both PKCι-dependent and PKCι-independent pathways to LADC development. Herein, we discussion our current knowledge of oncogenic PKCι signaling in LADC and LSCC, and discuss these findings in the context of how they may inform strategies for improved therapeutic intervention in these deadly diseases.

Original languageEnglish (US)
Article number100656
JournalAdvances in Biological Regulation
StatePublished - Jan 2020



  • Genetically-engineered mouse models
  • Lung adenocarcinoma
  • Lung squamous cell carcinoma
  • Oncogenic signaling pathways
  • Protein kinase Cι

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this